• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病血浆样本中异常循环 miRNA 的鉴定。

Identification of aberrant circulating miRNAs in Parkinson's disease plasma samples.

机构信息

Department of NeurologyTianjin Huan Hu Hospital Jinnan District, Tianjin China.

Tianjin Key Laboratory of Cerebrovascular and Neurodegenerative Diseases Tianjin China.

出版信息

Brain Behav. 2018 Feb 19;8(4):e00941. doi: 10.1002/brb3.941. eCollection 2018 Apr.

DOI:10.1002/brb3.941
PMID:29670823
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5893342/
Abstract

OBJECTIVE

To detect the aberrant expression of circulating miRNAs and explore the potential early diagnostic biomarkers in patients with Parkinson's disease (PD).

METHODS

Plasma samples were collected from 25 treatment-naïve PD-diagnosed patients and 25 healthy controls followed by a real-time PCR-based miRNA screening analysis of neuron disease-related miRNAs.

RESULTS

A subset of miRNAs with aberrant expression levels in the plasma of PD-diagnosed patients were identified including upregulation of miR-27a and downregulation of let-7a, let-7f, miR-142-3p, and miR-222 with the AUC values more than 0.8 derived from the receiver operating characteristic curves.

CONCLUSIONS

The high sensitivity and specificity of the circulating miRNAs may enable early diagnosis of PD. The study provides a group of novel miRNA candidates for detecting PD.

摘要

目的

检测循环 miRNA 的异常表达,探索帕金森病(PD)患者潜在的早期诊断生物标志物。

方法

收集 25 例未经治疗的 PD 确诊患者和 25 例健康对照者的血浆样本,随后进行基于实时 PCR 的神经元疾病相关 miRNA 的 miRNA 筛选分析。

结果

鉴定出一组在 PD 确诊患者血浆中表达异常的 miRNAs,包括 miR-27a 的上调和 let-7a、let-7f、miR-142-3p 和 miR-222 的下调,其 AUC 值大于来自受试者工作特征曲线的 0.8。

结论

循环 miRNA 的高灵敏度和特异性可能使 PD 能够早期诊断。该研究为检测 PD 提供了一组新的 miRNA 候选物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e88/5893342/a3b6456ee595/BRB3-8-e00941-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e88/5893342/329b42a90f12/BRB3-8-e00941-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e88/5893342/7e6ba334d637/BRB3-8-e00941-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e88/5893342/1c401f876e4e/BRB3-8-e00941-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e88/5893342/a3b6456ee595/BRB3-8-e00941-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e88/5893342/329b42a90f12/BRB3-8-e00941-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e88/5893342/7e6ba334d637/BRB3-8-e00941-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e88/5893342/1c401f876e4e/BRB3-8-e00941-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e88/5893342/a3b6456ee595/BRB3-8-e00941-g004.jpg

相似文献

1
Identification of aberrant circulating miRNAs in Parkinson's disease plasma samples.帕金森病血浆样本中异常循环 miRNA 的鉴定。
Brain Behav. 2018 Feb 19;8(4):e00941. doi: 10.1002/brb3.941. eCollection 2018 Apr.
2
Identification of a panel of five serum miRNAs as a biomarker for Parkinson's disease.鉴定一组五个血清微小RNA作为帕金森病的生物标志物。
Parkinsonism Relat Disord. 2016 Jan;22:68-73. doi: 10.1016/j.parkreldis.2015.11.014. Epub 2015 Nov 21.
3
Several miRNAs derived from serum extracellular vesicles are potential biomarkers for early diagnosis and progression of Parkinson's disease.几种来源于血清细胞外囊泡的 miRNA 可能是帕金森病早期诊断和进展的潜在生物标志物。
Transl Neurodegener. 2021 Jul 28;10(1):25. doi: 10.1186/s40035-021-00249-y.
4
Elevated plasma miR-133b and miR-221-3p as biomarkers for early Parkinson's disease.血浆 miR-133b 和 miR-221-3p 升高可作为早期帕金森病的生物标志物。
Sci Rep. 2021 Jul 27;11(1):15268. doi: 10.1038/s41598-021-94734-z.
5
MicroRNA biomarkers of Parkinson's disease in serum exosome-like microvesicles.血清中外泌体样微泡中帕金森病的微小RNA生物标志物
Neurosci Lett. 2017 Mar 22;644:94-99. doi: 10.1016/j.neulet.2017.02.045. Epub 2017 Feb 20.
6
Serum microRNA expression levels in Turkish patients with Parkinson's disease.土耳其帕金森病患者血清 microRNA 表达水平。
Int J Neurosci. 2021 Dec;131(12):1181-1189. doi: 10.1080/00207454.2020.1784165. Epub 2020 Jun 25.
7
A panel of four decreased serum microRNAs as a novel biomarker for early Parkinson's disease.一组四种血清微小RNA减少作为早期帕金森病的新型生物标志物。
Biomarkers. 2016;21(2):129-37. doi: 10.3109/1354750X.2015.1118544. Epub 2015 Dec 3.
8
Identification of plasma microRNA expression changes in multiple system atrophy and Parkinson's disease.多系统萎缩症和帕金森病患者血浆中微小 RNA 表达变化的鉴定。
Mol Brain. 2019 May 14;12(1):49. doi: 10.1186/s13041-019-0471-2.
9
Plasma levels of miR-137 and miR-124 are associated with Parkinson's disease but not with Parkinson's disease with depression.血浆中miR-137和miR-124的水平与帕金森病相关,但与伴发抑郁的帕金森病无关。
Neurol Sci. 2017 May;38(5):761-767. doi: 10.1007/s10072-017-2841-9. Epub 2017 Feb 8.
10
A compound downregulation of SRRM2 and miR-27a-3p with upregulation of miR-27b-3p in PBMCs of Parkinson's patients is associated with the early stage onset of disease.帕金森病患者 PBMC 中 SRRM2 和 miR-27a-3p 的复合下调与 miR-27b-3p 的上调与疾病的早期发病有关。
PLoS One. 2020 Nov 10;15(11):e0240855. doi: 10.1371/journal.pone.0240855. eCollection 2020.

引用本文的文献

1
Dysregulated microRNAs in blood correlate with central nervous system neuropathology of prion disease.血液中失调的微小RNA与朊病毒病的中枢神经系统神经病理学相关。
Vet Res. 2025 Jul 1;56(1):132. doi: 10.1186/s13567-025-01566-0.
2
MicroRNA let-7f protects against HO-induced oxidative damage in neuroblastoma cells by targeting AKT-2.微小RNA let-7f通过靶向AKT-2保护神经母细胞瘤细胞免受HO诱导的氧化损伤。
Arch Med Sci. 2020 Apr 19;21(2):648-657. doi: 10.5114/aoms.2020.94490. eCollection 2025.
3
Modulation of ZnT-1 by Let7a unveils a therapeutic potential in amyotrophic lateral sclerosis.

本文引用的文献

1
Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer's Disease: Potential and Limitations.血浆 miR-34a-5p 和 miR-545-3p 作为阿尔茨海默病的早期生物标志物:潜力和局限性。
Mol Neurobiol. 2017 Sep;54(7):5550-5562. doi: 10.1007/s12035-016-0088-8. Epub 2016 Sep 8.
2
miR-27a and miR-27b regulate autophagic clearance of damaged mitochondria by targeting PTEN-induced putative kinase 1 (PINK1).微小RNA-27a和微小RNA-27b通过靶向PTEN诱导的假定激酶1(PINK1)来调节受损线粒体的自噬清除。
Mol Neurodegener. 2016 Jul 26;11(1):55. doi: 10.1186/s13024-016-0121-4.
3
microRNA Profiles in Parkinson's Disease Prefrontal Cortex.
Let7a对锌转运蛋白1(ZnT-1)的调节揭示了肌萎缩侧索硬化症的治疗潜力。
Neurotherapeutics. 2025 Apr;22(3):e00571. doi: 10.1016/j.neurot.2025.e00571. Epub 2025 Mar 19.
4
An Overview of Epigenetic Changes in the Parkinson's Disease Brain.帕金森病大脑中的表观遗传学改变概述。
Int J Mol Sci. 2024 Jun 3;25(11):6168. doi: 10.3390/ijms25116168.
5
MicroRNA biomarkers as next-generation diagnostic tools for neurodegenerative diseases: a comprehensive review.微小RNA生物标志物作为神经退行性疾病的下一代诊断工具:综述
Front Mol Neurosci. 2024 May 31;17:1386735. doi: 10.3389/fnmol.2024.1386735. eCollection 2024.
6
Mechanistic Evaluation of miRNAs and Their Targeted Genes in the Pathogenesis and Therapeutics of Parkinson's Disease.miRNA及其靶向基因在帕金森病发病机制与治疗中的机制评估
Mol Neurobiol. 2025 Jan;62(1):91-108. doi: 10.1007/s12035-024-04261-x. Epub 2024 Jun 1.
7
Plasma miR-203a-3p as a Novel Predictor of Dementia in Patients with Parkinson's Disease.血浆 miR-203a-3p 作为帕金森病患者痴呆的新型预测因子。
Int J Mol Sci. 2024 Mar 21;25(6):3554. doi: 10.3390/ijms25063554.
8
Exosomal microRNAs in Parkinson's disease: insights into biomarker potential and disease pathology.帕金森病中的细胞外体 microRNAs:对生物标志物潜力和疾病发病机制的深入了解。
Neurol Sci. 2024 Aug;45(8):3625-3639. doi: 10.1007/s10072-024-07439-2. Epub 2024 Mar 27.
9
MicroRNA as a potential diagnostic and prognostic biomarker in brain gliomas: a systematic review and meta-analysis.微小RNA作为脑胶质瘤潜在的诊断和预后生物标志物:一项系统综述和荟萃分析
Front Neurol. 2024 Feb 29;15:1357321. doi: 10.3389/fneur.2024.1357321. eCollection 2024.
10
MicroRNAs in Parkinson's disease: a systematic review and diagnostic accuracy meta-analysis.帕金森病中的 microRNAs:系统评价和诊断准确性荟萃分析。
Sci Rep. 2023 Sep 28;13(1):16272. doi: 10.1038/s41598-023-43096-9.
帕金森病前额叶皮质中的微小RNA谱
Front Aging Neurosci. 2016 Mar 1;8:36. doi: 10.3389/fnagi.2016.00036. eCollection 2016.
4
miRNAs as Circulating Biomarkers for Alzheimer's Disease and Parkinson's Disease.作为阿尔茨海默病和帕金森病循环生物标志物的微小RNA
Med Chem. 2016;12(3):217-25. doi: 10.2174/1573406411666151030112140.
5
Check and mate to exosomal extracellular miRNA: new lesson from a new approach.外泌体细胞外 miRNA 的检查与将军:新方法的新启示。
Front Mol Biosci. 2015 Apr 13;2:11. doi: 10.3389/fmolb.2015.00011. eCollection 2015.
6
Role of MicroRNA Let-7 in Modulating Multifactorial Aspect of Neurodegenerative Diseases: an Overview.微小RNA Let-7在调节神经退行性疾病多因素方面的作用:综述
Mol Neurobiol. 2016 Jul;53(5):2787-2793. doi: 10.1007/s12035-015-9145-y. Epub 2015 Apr 1.
7
Circulating microRNAs as Promising Tumor Biomarkers.循环微RNA作为有前景的肿瘤生物标志物
Adv Clin Chem. 2014;67:189-214. doi: 10.1016/bs.acc.2014.09.007. Epub 2014 Nov 4.
8
MicroRNA-30a-5p in the prefrontal cortex controls the transition from moderate to excessive alcohol consumption.前额叶皮质中的微小RNA-30a-5p控制着从适度饮酒到过度饮酒的转变。
Mol Psychiatry. 2015 Oct;20(10):1219-31. doi: 10.1038/mp.2014.120. Epub 2014 Oct 21.
9
Identification of a set of endogenous reference genes for miRNA expression studies in Parkinson's disease blood samples.帕金森病血液样本中用于miRNA表达研究的一组内源性参考基因的鉴定。
BMC Res Notes. 2014 Oct 10;7:715. doi: 10.1186/1756-0500-7-715.
10
MiRNA profile in the substantia nigra of Parkinson's disease and healthy subjects.帕金森病患者与健康受试者黑质中的微小RNA谱。
J Mol Neurosci. 2014 Dec;54(4):830-6. doi: 10.1007/s12031-014-0428-y. Epub 2014 Oct 5.